$500,000 term vs whole life: the canonical BTID comparison, with twenty years of math.

Section 1

Why $500,000 is the canonical benchmark.

Almost every reference to buy term and invest the difference in personal finance writing anchors at $500,000. The reasons are both demographic and arithmetic. $500,000 is the rough midpoint of in-force individual life insurance face amounts in the United States: not so small that it is a final-expense product, not so large that it requires elaborate underwriting or estate planning. It is the amount a 30-something professional with a young family would consider as a serious income-replacement number, and it sits at a tier where both term and whole life are widely available from every major carrier without product-tier complications.

The arithmetic reason is that the absolute dollar premium gap at $500,000 is large enough to be motivating without being prohibitive. A $350 to $450 per month premium difference is exactly the kind of number that, automated into a brokerage account every month, builds a visible second portfolio over twenty years. The buyer can see the difference in their balance, not in a hypothetical illustration. That visibility, more than the underlying math, is what has made $500,000 the worked example of choice in personal finance writing for half a century.

Section 2

The 2026 rate ledger at $500,000.

Monthly premiums for $500,000 of coverage. Healthy non-smokers, illustrative ranges.

Term ranges aggregated from Policygenius broker quotes (Banner, Pacific Life, Protective, Haven Life). Whole life from dividend-paying mutuals (Northwestern Mutual, MassMutual, Guardian, New York Life, Penn Mutual). All numbers as of 2026 and may shift quarterly with carrier rate filings administered by state Departments of Insurance under NAIC model regulations.

Section 3

The twenty-year BTID ledger at $500,000.

A healthy 35-year-old male picks up $500,000 of 20-year term at roughly $34 per month and chooses not to buy the $440 per month whole life alternative. The monthly delta is $406. Held in a checking account for 20 years, that money totals $97,440. Compounded monthly at 5 percent for 20 years, it grows to roughly $167,000. At 7 percent, roughly $214,000. At 10 percent, roughly $311,000.

The whole life cash value comparison is sensitive to dividend assumptions. At the carrier's current illustrated dividend scale, a top-five mutual whole life policy on a healthy 35-year-old male at $500,000 face typically projects cash value at year 20 in the range of $95,000 to $115,000. At a flat dividend scale (no dividend growth from the current declared rate), the projection is materially lower, often $75,000 to $90,000. At a dividend scale fifteen percent below current illustrated (a stress-test the National Association of Insurance Commissioners and many internal carrier illustrations both consider reasonable), the projection drops further still.

So the honest comparison, at $500,000 over 20 years for a 35-year-old, runs roughly: BTID at a historical-average 7 percent return produces about $214,000 of brokerage assets; whole life under its own illustrated dividend produces about $105,000 of cash value, with the surrender charge already amortised. The buy-term-invest path produces approximately twice the wealth, with the same $500,000 of death benefit during the entire 20-year window. The difference at year 20 is the buy-term buyer owns $214,000 of liquid index funds; the whole life buyer owns $105,000 of cash value embedded in a policy that still has a death benefit running into old age. Both paths can be defended. The math just isn't close at this tier.

What happens after year 20 depends entirely on whether the household still needs life insurance. For a 55-year-old whose children are independent, whose mortgage is largely paid down, and who has retirement savings, the death benefit is genuinely valuable only to the surviving spouse, and only if the surviving spouse is not financially independent. For many households at that stage, the death benefit is no longer urgent. The whole life policyholder pays for it anyway; the BTID buyer reallocates the premium toward other goals.

Section 4

Carrier-by-carrier on the term side.

At $500,000, the term market is broad and competitive. The lowest-priced 20-year term for a healthy 35-year-old male in most states is typically offered by Banner Life, Pacific Life, Protective Life, Pennsylvania Life, or one of two or three other top-tier rate-aggressive carriers. Online accelerated-underwriting alternatives like Haven Life (a MassMutual subsidiary), Ladder, Bestow, Ethos, and Sproutt offer comparable pricing in exchange for a faster application process and (in most cases) no medical exam for healthy applicants under specified age and coverage thresholds.

The price spread between the cheapest and most expensive top-rated carrier for the same risk profile is typically 25 to 50 percent at $500,000. That spread is wider than at lower coverage tiers because $500,000 sits at a coverage band where some carriers use it as a price-leader to acquire customers and others price it conservatively. Brokers like Policygenius, Quotacy, and Term4Sale generally surface the price spread quickly. The practical recommendation is to compare at least three carriers, prefer carriers with an A or A+ rating from AM Best, and not over-optimise on the last $2 per month if a slightly more expensive A+ carrier offers a stronger conversion clause.

On the whole life side, the dividend-paying mutual carriers operate in a much narrower oligopoly. Northwestern Mutual, MassMutual, Guardian, New York Life, and Penn Mutual together write the majority of dividend-paying whole life premium in the US market. Mutual of Omaha competes in the simplified-issue tier. Pricing among the top five mutuals at $500,000 is broadly comparable; the meaningful differences are in dividend history (Northwestern Mutual and MassMutual have the longest continuous dividend records), policy loan provisions, paid-up additions rider design, and the carrier's underwriting class generosity.

Section 5

The case for whole life at $500,000.

A balanced presentation has to acknowledge where whole life at this tier has genuine merit. The cleanest case is a high earner who has already maxed every tax-advantaged account, has substantial taxable investments, and is looking for a small permanent allocation specifically for liquidity-without-tax during retirement. A $500,000 whole life policy from a top-rated mutual, funded for 20 years and then drawn against via policy loans during retirement, can deliver several thousand dollars per year of essentially tax-free supplemental cash flow under current tax law. The death benefit at death is reduced by the outstanding loan balance, but the loan was never taxable income.

A second defensible case is a buy-sell agreement between two business partners where the business itself owns $500,000 of whole life on each partner. The permanent nature of the coverage means the buy-sell mechanism does not need to be re-funded every 10 or 20 years; the term-expiry risk is removed. For partnerships with 30-plus-year time horizons (multi-generational family businesses, long-running professional practices), the certainty of permanent coverage is worth the premium.

A third is the buyer with a known progressive medical condition who is approved for $500,000 of whole life today but expects to be declined for term renewal at age 55 or 60. Locking in $500,000 of permanent insurability is a genuine value, and the BTID alternative does not capture it. The math here is no longer about expected return; it is about probability of being insurable at a future date.

Section 6

Commission math at the benchmark tier.

A $500,000 whole life policy at $440 per month for a healthy 35-year-old produces $5,280 of first-year premium. The selling agent typically earns 55 to 95 percent of first-year premium for whole life from a top-five mutual, which is $2,904 to $5,016 in year one alone. The same agent selling the equivalent $500,000 20-year term policy at $34 per month produces $408 of first-year premium, with a 35 to 50 percent commission, or roughly $143 to $204.

The commission ratio between the two products at the same face amount, sold to the same person, is approximately 20 to 25 times in favour of whole life. None of this is hidden; it is disclosed in the agent's contract with the carrier and would be visible in any state-required disclosure document. But it is rarely volunteered. The cleanest test is to ask the agent in writing: what is your commission on this product in year one and in years two through ten, and would you receive a higher commission for selling me the whole life versus the term at the same coverage amount. An agent who answers candidly is treating the relationship as fiduciary. An agent who deflects is not.

Section 7

Caveats and sourcing.

Death benefits are income-tax-free to a named beneficiary under IRC §101. Cash value growth in a policy that satisfies the Section 7702 definition of life insurance is tax-deferred. Estate inclusion under IRC §2042 applies if the insured owned the policy at death. Modified endowment contract treatment under IRC §7702A changes the tax treatment of policy loans and partial withdrawals if the policy fails the seven-pay test.

The Life Insurance Marketing and Research Association (LIMRA) and the American Council of Life Insurers publish annual industry data on in-force coverage, premium volume, and dividend history. The Insurance Information Institute and the Society of Actuaries publish mortality tables and educational material on life insurance product mechanics. This page is educational content and not insurance advice; consult a state-licensed insurance professional before binding any policy at this coverage tier.

Frequently asked

Common $500k questions.